IMPAACT 2009 (DAIDS ID 30020)

Phase:Demo Project
Principal Investigator(s):
Objective:Parallel, observational cohort study of HIV-uninfected pregnant adolescents and young women (aged 16-24). The study is designed to characterize adherence over time among women who initiate once daily oral PrEP during pregnancy and continue in the first 6 months following delivery, and to compare pregnancy outcomes among women who take PrEP and women who decline PrEP during the antenatal period.
Prevention Option(s):PrEP
Study Design:
Official Code: IMPAACT 2009 (DAIDS ID 30020) (
Trial Sponsors: International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network
Start Date
End Date
Age range: 16 Years ↔ 24 Years
Population:Cisgender Women